Osmozis SA
Osmozis SA Fundamental Analysis
Osmozis SA (ALOSM.PA) shows weak financial fundamentals with a PE ratio of 47.68, profit margin of 5.53%, and ROE of 5.90%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ALOSM.PA's fundamental strength across five key dimensions:
Efficiency Score
WeakALOSM.PA struggles to generate sufficient returns from assets.
Valuation Score
ModerateALOSM.PA shows balanced valuation metrics.
Growth Score
ModerateALOSM.PA shows steady but slowing expansion.
Financial Health Score
ExcellentALOSM.PA maintains a strong and stable balance sheet.
Profitability Score
WeakALOSM.PA struggles to sustain strong margins.
Key Financial Metrics
Is ALOSM.PA Expensive or Cheap?
P/E Ratio
ALOSM.PA trades at 47.68 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ALOSM.PA's PEG of 0.48 indicates potential undervaluation.
Price to Book
The market values Osmozis SA at 2.13 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 9.13 times EBITDA. This is generally considered low.
How Well Does ALOSM.PA Make Money?
Net Profit Margin
For every $100 in sales, Osmozis SA keeps $5.53 as profit after all expenses.
Operating Margin
Core operations generate 12.52 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $5.90 in profit for every $100 of shareholder equity.
ROA
Osmozis SA generates $2.06 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Osmozis SA generates strong operating cash flow of $5.00M, reflecting robust business health.
Free Cash Flow
Osmozis SA generates weak or negative free cash flow of $-729.23K, restricting financial flexibility.
FCF Per Share
Each share generates $-0.26 in free cash annually.
FCF Yield
ALOSM.PA converts -1.41% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
47.68
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.48
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.13
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.27
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.90
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.62
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How ALOSM.PA Stacks Against Its Sector Peers
| Metric | ALOSM.PA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 47.68 | 22.91 | Worse (Expensive) |
| ROE | 5.90% | 1005.00% | Weak |
| Net Margin | 5.53% | -60132.00% (disorted) | Weak |
| Debt/Equity | 0.90 | 1.28 | Strong (Low Leverage) |
| Current Ratio | 2.62 | 1.65 | Strong Liquidity |
| ROA | 2.06% | -581836.00% (disorted) | Weak |
ALOSM.PA outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Osmozis SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Technology, Streaming
EPS CAGR
N/A
Industry Style: Growth, Technology, Streaming
FCF CAGR
N/A
Industry Style: Growth, Technology, Streaming